Discovery of Bis-imidazolecarboxamide Derivatives as Novel, Potent, and Selective TNIK Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis
- 18 October 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 67 (21) , 19121-19142
Abstract
Traf2- and Nck-interacting kinase (TNIK) has been identified as a promising therapeutic target for the treatment of fibrosis-driven diseases. Utilizing a structure-based drug design workflow, we developed a series of potent TNIK inhibitors that modulate the conformation of the gatekeeper Met105 side chain and access the TNIK back pocket. The lead optimization efforts culminated in the discovery of the recently reported compound 4 (INS018_055), a novel TNIK inhibitor. This molecule demonstrated excellent activity in both enzymatic and cell-based assays, along with high selectivity in a kinome panel. Further, in vitro and in vivo preclinical studies revealed favorable in vitro and in vivo DMPK properties. Results from multiple cell-based and animal models proved that compound 4 exhibits considerable antifibrotic and anti-inflammatory efficacy. Currently, phase II clinical trials of compound 4 are underway for the treatment of idiopathic pulmonary fibrosis (IPF).Keywords
This publication has 40 references indexed in Scilit:
- LKB1 loss promotes colorectal cancer cell metastasis through regulating TNIK expression and actin cytoskeleton remodelingMolecular Carcinogenesis, 2023
- TNIK Inhibition Has Dual Synergistic Effects on Tumor and Associated Immune CellsAdvanced Biology, 2022
- Traf2 and NCK Interacting Kinase Is a Critical Regulator of Procollagen I Trafficking and Hepatic Fibrogenesis in MiceHepatology Communications, 2021
- Latest progress on the molecular mechanisms of idiopathic pulmonary fibrosisMolecular Biology Reports, 2020
- Effect of TNIK upregulation on JQ1-resistant human colorectal cancer HCT116 cellsBiochemical and Biophysical Research Communications, 2020
- The Misshapen subfamily of Ste20 kinases regulate proliferation in the aging mammalian intestinal epitheliumJournal of Cellular Physiology, 2019
- Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancerPharmacology & Therapeutics, 2015
- Discovery of 4-phenyl-2-phenylaminopyridine based TNIK inhibitorsBioorganic & Medicinal Chemistry Letters, 2013
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- Interleukin–10 Expression and Function in Experimental Murine Liver Inflammation and FibrosisHepatology, 1998